Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 370

1.

Comparison of T2*GRE and DSC-PWI for hemorrhage detection in acute ischemic stroke patients: Pooled analysis of the EPITHET, DEFUSE 2, and SENSE 3 stroke studies.

Amukotuwa SA, Fischbein NJ, Albers GW, Davis S, Donnan GA, Andre JB, Bammer R.

Int J Stroke. 2019 Jul 10:1747493019858781. doi: 10.1177/1747493019858781. [Epub ahead of print]

PMID:
31291850
2.

Thrombectomy Results in Reduced Hospital Stay, More Home-Time, and More Favorable Living Situations in DEFUSE 3.

Tate WJ, Polding LC, Kemp S, Mlynash M, Heit JJ, Marks MP, Albers GW, Lansberg MG.

Stroke. 2019 Jul 10:STROKEAHA119025165. doi: 10.1161/STROKEAHA.119.025165. [Epub ahead of print]

PMID:
31288666
3.

Time Course for Benefit and Risk of Clopidogrel and Aspirin after Acute Transient Ischemic Attack and Minor Ischemic Stroke: A Secondary Analysis from the POINT Randomized Trial.

Johnston SC, Elm JJ, Easton JD, Farrant M, Barsan WG, Kim AS, Lindblad AS, Palesch YY, Zurita KG, Albers GW, Cucchiara BL, Kleindorfer DO, Lutsep HL, Pearson C, Sethi P, Vora N; POINT and Neurological Emergencies Treatment Trials Network Investigators.

Circulation. 2019 Jun 26. doi: 10.1161/CIRCULATIONAHA.119.040713. [Epub ahead of print]

PMID:
31238700
4.

Advanced Brain Imaging in Late-Arriving Drip and Ship Patients With Known Large Vessel Occlusion.

Albers GW, Molina CA, Selim MH, Jovin TG.

Stroke. 2019 Jul;50(7):1940-1943. doi: 10.1161/STROKEAHA.118.020574. Epub 2019 Jun 20. No abstract available.

PMID:
31216963
5.

STAIR X: Trial Design Considerations and Additional Populations to Expand Indications for Endovascular Treatment.

Demchuk AM, Albers GW, Nogueira RG; STAIR X Consortium *; STAIR X (Stroke Treatment Academic Industry Roundtable) writing contributors.

Stroke. 2019 Apr 23:STROKEAHA119024337. doi: 10.1161/STROKEAHA.119.024337. [Epub ahead of print] No abstract available.

PMID:
31112484
6.

Neuroimaging selection for thrombectomy in pediatric stroke: a single-center experience.

Lee S, Heit JJ, Albers GW, Wintermark M, Jiang B, Bernier E, Fischbein NJ, Mlynash M, Marks MP, Do HM, Dodd RL.

J Neurointerv Surg. 2019 May 16. pii: neurintsurg-2019-014862. doi: 10.1136/neurintsurg-2019-014862. [Epub ahead of print]

PMID:
31097548
7.

Artificial Neural Network Computer Tomography Perfusion Prediction of Ischemic Core.

Kasasbeh AS, Christensen S, Parsons MW, Campbell B, Albers GW, Lansberg MG.

Stroke. 2019 Jun;50(6):1578-1581. doi: 10.1161/STROKEAHA.118.022649. Epub 2019 May 16.

PMID:
31092162
8.

Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the SOCRATES trial.

Easton JD, Denison H, Evans SR, Knutsson M, Amarenco P, Albers GW, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KL, Johnston SC; SOCRATES Steering Committee and Investigators.

Int J Stroke. 2019 May 15:1747493019851282. doi: 10.1177/1747493019851282. [Epub ahead of print]

PMID:
31092152
9.

Response by de Havenon et al to Letter Regarding Article, "Results From DEFUSE 3: Good Collaterals Are Associated With Reduced Ischemic Core Growth but Not Neurologic Outcome".

de Havenon A, Albers GW, Heit JJ.

Stroke. 2019 Jun;50(6):e166. doi: 10.1161/STROKEAHA.119.025713. Epub 2019 May 14. No abstract available.

PMID:
31084323
10.

Thrombectomy with Conscious Sedation Compared with General Anesthesia: A DEFUSE 3 Analysis.

Powers CJ, Dornbos D 3rd, Mlynash M, Gulati D, Torbey M, Nimjee SM, Lansberg MG, Albers GW, Marks MP.

AJNR Am J Neuroradiol. 2019 Jun;40(6):1001-1005. doi: 10.3174/ajnr.A6059. Epub 2019 May 9.

PMID:
31072970
11.

Collateral blood flow measurement with intravoxel incoherent motion perfusion imaging in hyperacute brain stroke.

Federau C, Wintermark M, Christensen S, Mlynash M, Marcellus DG, Zhu G, Martin BW, Lansberg MG, Albers GW, Heit JJ.

Neurology. 2019 May 21;92(21):e2462-e2471. doi: 10.1212/WNL.0000000000007538. Epub 2019 Apr 24.

PMID:
31019105
12.

Multimodal magnetic resonance imaging to identify stroke onset within 6 h in patients with large vessel occlusions.

Wouters A, Dupont P, Christensen S, Norrving B, Laage R, Thomalla G, Kemp S, Lansberg M, Thijs V, Albers GW, Lemmens R.

Eur Stroke J. 2018 Jun;3(2):185-192. doi: 10.1177/2396987317753486. Epub 2018 Feb 1.

13.

Response to letter by Samuels et al.

Brinjikji W, Albers GW, Koch S, Rabinstein AA.

Int J Stroke. 2019 Jun;14(4):NP3. doi: 10.1177/1747493019840929. Epub 2019 Apr 1. No abstract available.

PMID:
30935348
14.

Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study.

Heit JJ, Mlynash M, Kemp SM, Lansberg MG, Christensen S, Marks MP, Ortega-Gutierrez S, Albers GW.

Stroke. 2019 May;50(5):1172-1177. doi: 10.1161/STROKEAHA.119.024928.

PMID:
30932783
15.

Hypoperfusion Intensity Ratio Is Correlated With Patient Eligibility for Thrombectomy.

Guenego A, Marcellus DG, Martin BW, Christensen S, Albers GW, Lansberg MG, Marks MP, Wintermark M, Heit JJ.

Stroke. 2019 Apr;50(4):917-922. doi: 10.1161/STROKEAHA.118.024134.

PMID:
30841821
16.

Validation and iteration of CT perfusion defined malignant profile thresholds for acute ischemic stroke.

Keenan KJ, Christensen S, Inoue M, Mlynash M, Albers GW, Smith WS.

Int J Stroke. 2019 Feb 22:1747493019832987. doi: 10.1177/1747493019832987. [Epub ahead of print]

PMID:
30794104
17.

Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial.

Molina CA, Johnston SC, Ladenvall P, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Knutsson M, Minematsu K, Röther J, Wang Y, Wong KSL; SOCRATES Steering Committee and Investigators.

Stroke. 2019 Mar;50(3):675-682. doi: 10.1161/STROKEAHA.118.022675. Erratum in: Stroke. 2019 Apr;50(4):e118.

PMID:
30776996
18.

Persistent Target Mismatch Profile >24 Hours After Stroke Onset in DEFUSE 3.

Christensen S, Mlynash M, Kemp S, Yennu A, Heit JJ, Marks MP, Lansberg MG, Albers GW.

Stroke. 2019 Mar;50(3):754-757. doi: 10.1161/STROKEAHA.118.023392.

PMID:
30735466
19.

Outcomes of Thrombectomy in Transferred Patients With Ischemic Stroke in the Late Window: A Subanalysis From the DEFUSE 3 Trial.

Sarraj A, Mlynash M, Savitz SI, Heit JJ, Lansberg MG, Marks MP, Albers GW.

JAMA Neurol. 2019 Feb 7. doi: 10.1001/jamaneurol.2019.0118. [Epub ahead of print]

PMID:
30734042
20.

DEFUSE 3 Non-DAWN Patients.

Leslie-Mazwi TM, Hamilton S, Mlynash M, Patel AB, Schwamm LH, Lansberg MG, Marks M, Hirsch JA, Albers GW.

Stroke. 2019 Mar;50(3):618-625. doi: 10.1161/STROKEAHA.118.023310.

PMID:
30727856
21.

Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3.

Rao V, Christensen S, Yennu A, Mlynash M, Zaharchuk G, Heit J, Marks MP, Lansberg MG, Albers GW.

Stroke. 2019 Mar;50(3):626-631. doi: 10.1161/STROKEAHA.118.023177.

PMID:
30727840
22.

Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial.

Lansberg MG, Mlynash M, Hamilton S, Yeatts SD, Christensen S, Kemp S, Lavori PW, Ortega-Gutierrez S, Broderick J, Heit J, Marks MP, Albers GW; DEFUSE 3 Investigators.

JAMA Neurol. 2019 Jan 28. doi: 10.1001/jamaneurol.2018.4587. [Epub ahead of print]

PMID:
30688974
23.

Mediation of the Relationship Between Endovascular Therapy and Functional Outcome by Follow-up Infarct Volume in Patients With Acute Ischemic Stroke.

Boers AMM, Jansen IGH, Brown S, Lingsma HF, Beenen LFM, Devlin TG, Román LS, Heo JH, Ribó M, Almekhlafi MA, Liebeskind DS, Teitelbaum J, Cuadras P, du Mesnil de Rochemont R, Beaumont M, Brown MM, Yoo AJ, Donnan GA, Mas JL, Oppenheim C, Dowling RJ, Moulin T, Agrinier N, Lopes DK, Aja Rodríguez L, Compagne KCJ, Al-Ajlan FS, Madigan J, Albers GW, Soize S, Blasco J, Davis SM, Nogueira RG, Dávalos A, Menon BK, van der Lugt A, Muir KW, Roos YBWEM, White P, Mitchell PJ, Demchuk AM, van Zwam WH, Jovin TG, van Oostenbrugge RJ, Dippel DWJ, Campbell BCV, Guillemin F, Bracard S, Hill MD, Goyal M, Marquering HA, Majoie CBLM.

JAMA Neurol. 2019 Feb 1;76(2):194-202. doi: 10.1001/jamaneurol.2018.3661.

PMID:
30615038
24.

Response by Demeestere et al to Letter Regarding Article, "Alberta Stroke Program Early CT Score Versus Computed Tomographic Perfusion to Predict Functional Outcome After Successful Reperfusion in Acute Ischemic Stroke".

Demeestere J, Albers GW, Lansberg M, Lemmens R.

Stroke. 2018 Nov 29:STROKEAHA118023955. doi: 10.1161/STROKEAHA.118.023955. [Epub ahead of print] No abstract available.

PMID:
30580744
25.

Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.

Campbell BCV, Majoie CBLM, Albers GW, Menon BK, Yassi N, Sharma G, van Zwam WH, van Oostenbrugge RJ, Demchuk AM, Guillemin F, White P, Dávalos A, van der Lugt A, Butcher KS, Cherifi A, Marquering HA, Cloud G, Macho Fernández JM, Madigan J, Oppenheim C, Donnan GA, Roos YBWEM, Shankar J, Lingsma H, Bonafé A, Raoult H, Hernández-Pérez M, Bharatha A, Jahan R, Jansen O, Richard S, Levy EI, Berkhemer OA, Soudant M, Aja L, Davis SM, Krings T, Tisserand M, San Román L, Tomasello A, Beumer D, Brown S, Liebeskind DS, Bracard S, Muir KW, Dippel DWJ, Goyal M, Saver JL, Jovin TG, Hill MD, Mitchell PJ; HERMES collaborators.

Lancet Neurol. 2019 Jan;18(1):46-55. doi: 10.1016/S1474-4422(18)30314-4. Epub 2018 Nov 6. Erratum in: Lancet Neurol. 2019 Mar;18(3):e2.

PMID:
30413385
26.

Alberta Stroke Program Early CT Score Versus Computed Tomographic Perfusion to Predict Functional Outcome After Successful Reperfusion in Acute Ischemic Stroke.

Demeestere J, Scheldeman L, Cornelissen SA, Heye S, Wouters A, Dupont P, Christensen S, Mlynash M, Albers GW, Lansberg M, Lemmens R.

Stroke. 2018 Oct;49(10):2361-2367. doi: 10.1161/STROKEAHA.118.021961.

PMID:
30355098
27.

Volumetric and Spatial Accuracy of Computed Tomography Perfusion Estimated Ischemic Core Volume in Patients With Acute Ischemic Stroke.

Hoving JW, Marquering HA, Majoie CBLM, Yassi N, Sharma G, Liebeskind DS, van der Lugt A, Roos YB, van Zwam W, van Oostenbrugge RJ, Goyal M, Saver JL, Jovin TG, Albers GW, Davalos A, Hill MD, Demchuk AM, Bracard S, Guillemin F, Muir KW, White P, Mitchell PJ, Donnan GA, Davis SM, Campbell BCV.

Stroke. 2018 Oct;49(10):2368-2375. doi: 10.1161/STROKEAHA.118.020846.

PMID:
30355095
28.

Use of Imaging to Select Patients for Late Window Endovascular Therapy.

Albers GW.

Stroke. 2018 Sep;49(9):2256-2260. doi: 10.1161/STROKEAHA.118.021011. No abstract available.

PMID:
30355004
29.

Endovascular thrombectomy in patients with large infarctions: reasons for restraint.

Albers GW.

Lancet Neurol. 2018 Oct;17(10):836-837. doi: 10.1016/S1474-4422(18)30273-4. Epub 2018 Sep 18. No abstract available.

PMID:
30264719
30.

Factors that may contribute to poor outcome despite good reperfusion after acute endovascular stroke therapy.

Rabinstein AA, Albers GW, Brinjikji W, Koch S.

Int J Stroke. 2019 Jan;14(1):23-31. doi: 10.1177/1747493018799979. Epub 2018 Sep 6.

PMID:
30188259
31.

Hypoperfusion ratio predicts infarct growth during transfer for thrombectomy.

Guenego A, Mlynash M, Christensen S, Kemp S, Heit JJ, Lansberg MG, Albers GW.

Ann Neurol. 2018 Oct;84(4):616-620. doi: 10.1002/ana.25320. Epub 2018 Sep 23.

PMID:
30168180
32.

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators.

N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.

33.

Endovascular Treatment in the DEFUSE 3 Study.

Marks MP, Heit JJ, Lansberg MG, Kemp S, Christensen S, Derdeyn CP, Rasmussen PA, Zaidat OO, Broderick JP, Yeatts SD, Hamilton S, Mlynash M, Albers GW; DEFUSE 3 Investigators.

Stroke. 2018 Aug;49(8):2000-2003. doi: 10.1161/STROKEAHA.118.022147.

PMID:
29986935
34.

Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.

Wong KSL, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Himmelmann A, Kasner SE, Knutsson M, Ladenvall P, Minematsu K, Molina CA, Wang Y, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2018 Jul;49(7):1678-1685. doi: 10.1161/STROKEAHA.118.020553. Epub 2018 Jun 18.

35.

Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke.

Amarenco P, Lavallée PC, Monteiro Tavares L, Labreuche J, Albers GW, Abboud H, Anticoli S, Audebert H, Bornstein NM, Caplan LR, Correia M, Donnan GA, Ferro JM, Gongora-Rivera F, Heide W, Hennerici MG, Kelly PJ, Král M, Lin HF, Molina C, Park JM, Purroy F, Rothwell PM, Segura T, Školoudík D, Steg PG, Touboul PJ, Uchiyama S, Vicaut É, Wang Y, Wong LKS; TIAregistry.org Investigators.

N Engl J Med. 2018 Jun 7;378(23):2182-2190. doi: 10.1056/NEJMoa1802712. Epub 2018 May 16.

36.

Thrombectomy for Stroke with Selection by Perfusion Imaging.

Albers GW, Marks MP, Lansberg MG.

N Engl J Med. 2018 May 10;378(19):1849-1850. doi: 10.1056/NEJMc1803856. No abstract available.

PMID:
29742373
37.

Early Cerebral Vein After Endovascular Ischemic Stroke Treatment Predicts Symptomatic Reperfusion Hemorrhage.

Cartmell SCD, Ball RL, Kaimal R, Telischak NA, Marks MP, Do HM, Dodd RL, Albers GW, Lansberg MG, Heit JJ.

Stroke. 2018 Jul;49(7):1741-1746. doi: 10.1161/STROKEAHA.118.021402. Epub 2018 May 8.

PMID:
29739912
38.

Association of follow-up infarct volume with functional outcome in acute ischemic stroke: a pooled analysis of seven randomized trials.

Boers AMM, Jansen IGH, Beenen LFM, Devlin TG, San Roman L, Heo JH, Ribó M, Brown S, Almekhlafi MA, Liebeskind DS, Teitelbaum J, Lingsma HF, van Zwam WH, Cuadras P, du Mesnil de Rochemont R, Beaumont M, Brown MM, Yoo AJ, van Oostenbrugge RJ, Menon BK, Donnan GA, Mas JL, Roos YBWEM, Oppenheim C, van der Lugt A, Dowling RJ, Hill MD, Davalos A, Moulin T, Agrinier N, Demchuk AM, Lopes DK, Aja Rodríguez L, Dippel DWJ, Campbell BCV, Mitchell PJ, Al-Ajlan FS, Jovin TG, Madigan J, Albers GW, Soize S, Guillemin F, Reddy VK, Bracard S, Blasco J, Muir KW, Nogueira RG, White PM, Goyal M, Davis SM, Marquering HA, Majoie CBLM.

J Neurointerv Surg. 2018 Dec;10(12):1137-1142. doi: 10.1136/neurintsurg-2017-013724. Epub 2018 Apr 7.

PMID:
29627794
39.

Automated DWI analysis can identify patients within the thrombolysis time window of 4.5 hours.

Wouters A, Cheng B, Christensen S, Dupont P, Robben D, Norrving B, Laage R, Thijs VN, Albers GW, Thomalla G, Lemmens R.

Neurology. 2018 May 1;90(18):e1570-e1577. doi: 10.1212/WNL.0000000000005413. Epub 2018 Apr 4.

PMID:
29618622
40.

Time From Imaging to Endovascular Reperfusion Predicts Outcome in Acute Stroke.

Tsai JP, Mlynash M, Christensen S, Kemp S, Kim S, Mishra NK, Federau C, Nogueira RG, Jovin TG, Devlin TG, Akhtar N, Yavagal DR, Bammer R, Straka M, Zaharchuk G, Marks MP, Albers GW, Lansberg MG; CRISP Investigators.

Stroke. 2018 Apr;49(4):952-957. doi: 10.1161/STROKEAHA.117.018858. Epub 2018 Mar 16.

41.

Can diffusion- and perfusion-weighted imaging alone accurately triage anterior circulation acute ischemic stroke patients to endovascular therapy?

Wolman DN, Iv M, Wintermark M, Zaharchuk G, Marks MP, Do HM, Dodd RL, Albers GW, Lansberg MG, Heit JJ.

J Neurointerv Surg. 2018 Dec;10(12):1132-1136. doi: 10.1136/neurintsurg-2018-013784. Epub 2018 Mar 19.

PMID:
29555872
42.

Reduced Intravoxel Incoherent Motion Microvascular Perfusion Predicts Delayed Cerebral Ischemia and Vasospasm After Aneurysm Rupture.

Heit JJ, Wintermark M, Martin BW, Zhu G, Marks MP, Zaharchuk G, Dodd RL, Do HM, Steinberg GK, Lansberg MG, Albers GW, Federau C.

Stroke. 2018 Mar;49(3):741-745. doi: 10.1161/STROKEAHA.117.020395. Epub 2018 Feb 9.

PMID:
29439196
43.

Late Window Paradox.

Albers GW.

Stroke. 2018 Mar;49(3):768-771. doi: 10.1161/STROKEAHA.117.020200. Epub 2018 Jan 24. Review. No abstract available.

PMID:
29367336
44.

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators.

N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24.

45.

Relative cerebral blood volume is associated with collateral status and infarct growth in stroke patients in SWIFT PRIME.

Arenillas JF, Cortijo E, García-Bermejo P, Levy EI, Jahan R, Liebeskind D, Goyal M, Saver JL, Albers GW.

J Cereb Blood Flow Metab. 2018 Oct;38(10):1839-1847. doi: 10.1177/0271678X17740293. Epub 2017 Nov 14. Erratum in: J Cereb Blood Flow Metab. 2018 Jan 1;:271678X18765354.

PMID:
29135347
46.

A Comparison of Relative Time to Peak and Tmax for Mismatch-Based Patient Selection.

Wouters A, Christensen S, Straka M, Mlynash M, Liggins J, Bammer R, Thijs V, Lemmens R, Albers GW, Lansberg MG.

Front Neurol. 2017 Oct 13;8:539. doi: 10.3389/fneur.2017.00539. eCollection 2017.

47.

A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3).

Albers GW, Lansberg MG, Kemp S, Tsai JP, Lavori P, Christensen S, Mlynash M, Kim S, Hamilton S, Yeatts SD, Palesch Y, Bammer R, Broderick J, Marks MP.

Int J Stroke. 2017 Oct;12(8):896-905. doi: 10.1177/1747493017701147. Epub 2017 Mar 24.

48.

Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.

Charidimou A, Turc G, Oppenheim C, Yan S, Scheitz JF, Erdur H, Klinger-Gratz PP, El-Koussy M, Takahashi W, Moriya Y, Wilson D, Kidwell CS, Saver JL, Sallem A, Moulin S, Edjlali-Goujon M, Thijs V, Fox Z, Shoamanesh A, Albers GW, Mattle HP, Benavente OR, Jäger HR, Ambler G, Aoki J, Baron JC, Kimura K, Kakuda W, Takizawa S, Jung S, Nolte CH, Lou M, Cordonnier C, Werring DJ.

Stroke. 2017 Aug;48(8):2084-2090. doi: 10.1161/STROKEAHA.116.012992. Review.

PMID:
28720659
49.

Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.

Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2017 Sep;48(9):2480-2487. doi: 10.1161/STROKEAHA.117.017217. Epub 2017 Jul 18.

PMID:
28720658
50.

Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes).

Easton JD, Aunes M, Albers GW, Amarenco P, Bokelund-Singh S, Denison H, Evans SR, Held P, Jahreskog M, Jonasson J, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Circulation. 2017 Sep 5;136(10):907-916. doi: 10.1161/CIRCULATIONAHA.117.028566. Epub 2017 Jun 27.

PMID:
28655834

Supplemental Content

Loading ...
Support Center